Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Sanofi and ImmunoGen amend cancer immunotherapy agreements

May 31, 2017

Array BioPharma and Bristol-Myers enter collaboration for binimetinib and nivolumab combination

May 30, 2017

Harpoon Therapeutics completes USD 45M series B financing

May 30, 2017

Galderma's resiquimod named U.S. orphan drug for cutaneous T-cell lymphoma

May 29, 2017

FDA grants priority review to axicabtagene ciloleucel BLA

May 29, 2017

Study evaluating NY-ESO SPEAR T cells plus pembrolizumab begins

May 26, 2017

FDA grants priority review to sBLA for Opdivo in previously treated HCC

May 25, 2017

EMA awards orphan drug designation to Actinium's Actimab-A

May 25, 2017

Pierre Fabre acquires immuno-oncology assets from Igenica Biotherapeutics

May 24, 2017

Debiopharm acquires ImmunoGen's ADC IMGN-529

May 24, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...